We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Must Report All Deaths in Trials, India Guidance Says
Sponsors Must Report All Deaths in Trials, India Guidance Says
Sponsors of clinical trials in India must begin reporting all deaths that occur “in clinical trials,” under final guidance issued in early March by the Central Drugs Standard Control Organization.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor